We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Rates of Prescribing Zidovudine Post Concorde Trial

Julio S. G. Montaner, MD, FRCPC, FCCP; Robert S. Hogg, PhD; Rick Le; Michael V. O'Shaughnessy, PhD; Martin T. Schechter, MD, MSc, PhD, FRCPC
JAMA. 1994;271(16):1239. doi:10.1001/jama.1994.03510400025020.
Text Size: A A A
Published online


To the Editor.  —We conducted the present analysis to assess the impact of the publication1 of the preliminary analysis of the Concorde Trial2 and its associated publicity3,4 on zidovudine utilization in the province of British Columbia. The distribution of antiretroviral drugs in British Columbia is free of charge through the provincial Centre for Excellence in HIV/AIDS [human immunodeficiency virus/acquired immunodeficiency syndrome]. In order for physicians to prescribe zidovudine, they complete a patient enrollment form that serves as the drug prescription. This application is usually accompanied by a CD4 cell count determination. Individuals infected with HIV are eligible to receive zidovudine from this program if they have at least one CD4 cell count less than 0.50 ×109/L (500/μL). There is no other legal source of zidovudine in the province.A total of 564 new zidovudine requests were received during the first 9 months of 1993. As


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.